Acqwired Blog

PE Research & Deal Sourcing Insights

Frameworks, tactics, and research from 35+ years of institutional deal sourcing — applied to the AI-native era.

Deal SourcingFeatured

Deal Sourcing Has Changed. Your Research Stack Hasn't.

From 1–3 bidders in 1985 to 50–200+ today — how the deal sourcing landscape evolved and why manual research is now the bottleneck to proprietary deal flow.

5 min readFebruary 18, 2026Acqwired Team
Read
Deal Sourcing

The Mamba Company: Why the Best Deals Are Invisible

High-growth, founder-owned companies with 90%+ customer retention don't need capital — so they never talk to PE. Here's how to find them before bankers do.

6 min readFebruary 15, 2026
BD & Outreach

Permissionless Value: How to Get Founders to Take Your Call

Generic PE outreach gets a 2% response rate. The firms winning founder conversations show up with something valuable first — before asking for anything.

5 min readFebruary 12, 2026
Deal Sourcing

The Engineering Mindset Applied to Deal Sourcing

How applying hypothesis-driven thinking, continuous improvement, and output measurement to BD creates a repeatable, scalable sourcing machine.

7 min readFebruary 10, 2026
BD & Outreach

AI Outreach Mistakes PE Firms Are Still Making

Generic AI-generated emails are flooding founder inboxes and burning hard-won banker relationships. Four critical mistakes — and how to avoid them.

5 min readFebruary 8, 2026
Deal Sourcing

The 90-Day BD Playbook: From Sponge Mode to Pipeline

A three-phase framework for new PE business development professionals to build relationships, learn sectors, and generate deal flow in their first quarter.

6 min readFebruary 5, 2026
Research & AI

Trust Over Data: Why Relationships Still Win in the AI Era

As AI commoditizes data and analytics, the only sustainable competitive edge in PE deal sourcing is the one thing algorithms can't replicate: trust.

5 min readFebruary 3, 2026
Market Intelligence

The Bifurcated Economy: Where PE Should Be Looking

AI is not disrupting markets uniformly. Understanding contestable vs. non-contestable markets — and Baumol's Cost Disease — reshapes where PE should be deploying capital.

7 min readJanuary 30, 2026